GATE2BRAIN

gate2brain-logo

Gate2Brain is an early-stage biotech company launched to improve drug delivery across biological barriers through the use of a radically innovative peptide-based patented technology. Its technology aims to transport drugs to the brain, increasing the efficiency and reducing the side effects of treatments for brain diseases.

#People #Financial #Website #More

GATE2BRAIN

Social Links:

Industry:
Biotechnology Medical

Address:
Barcelona, Catalonia, Spain

Country:
Spain

Website Url:
http://www.gate2brain.com

Total Employee:
1+

Status:
Active

Total Funding:
100 K EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics


Current Employees Featured

gloria-sancliments_image

Gloria Sancliments
Gloria Sancliments COO, Product Development & Founder @ Gate2Brain
COO, Product Development & Founder
2020-07-01

meritxell-teixido_image

Meritxell Teixido
Meritxell Teixido Founder & CEO/CSO @ Gate2Brain
Founder & CEO/CSO
2020-07-01

Founder


gloria-sancliments_image

Gloria Sancliments

meritxell-teixido_image

Meritxell Teixido

Investors List

bstartup-llc_image

BStartup

BStartup investment in Venture Round - Gate2Brain

Official Site Inspections

http://www.gate2brain.com

  • Host name: 213.158.93.71.static.teamblue-ops.net
  • IP address: 213.158.93.71
  • Location: Italy
  • Latitude: 43.1479
  • Longitude: 12.1097
  • Timezone: Europe/Rome

Loading ...

More informations about "Gate2Brain"

Home - Gate2Brain

Apr 29, 2025 Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We pursue our goals using โ€ฆSee details»

Company - Gate2Brain

Gate2Brain aims to become a world leading company with a cutting-edge technology, able to improve drug distribution to desired targets and to bring drug candidates closer to clinical โ€ฆSee details»

About us - Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology. Where to find us. โ€ฆSee details»

Gate2Brain - Crunchbase Company Profile & Funding

Gate2Brain is an early-stage biotech company launched to improve drug delivery across biological barriers through the use of a radically innovative peptide โ€ฆSee details»

Gate2Brain - LinkedIn

Gate2Brain | 2,982 followers on LinkedIn. A novel technology platform for the delivery of therapeutics across biological barriers | Gate2Brain is a biotech company focused on the development of ...See details»

Gate2Brain - Org Chart, Teams, Culture & Jobs - The Org

Gate2Brain is an early-stage biotech company launched to improve drug delivery across biological barriers through the use of a radically innovative peptide-based patented technology. Its technology aims to transport drugs to the brain, โ€ฆSee details»

Gate2Brain - Company Profile

Gate2Brain. Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. Gate2Brain pursues its โ€ฆSee details»

Gate2Brain - 2025 Company Profile, Funding & Competitors - Tracxn

Mar 28, 2025 Gate2Brain has raised funding over 2 rounds. Its first funding round was on Oct 05, 2022. Its latest funding round was a Grant (prize money) round on Aug 01, 2023 for โ€ฆSee details»

Gate2Brain 2025 Company Profile: Valuation, Funding โ€ฆ

Gate2Brain General Information Description. Developer of a novel technology platform designed to deliver therapeutics across biological barriers. The company focuses on the development of therapeutics that efficiently cross biological โ€ฆSee details»

Future-Proof Organizations โ€“ G2B Team Building

May 8, 2024 Our context, as a dynamic and motivated organization founded in 2020, with a growing team, presents a myriad of challenges. ... This activity was possible thanks to the Senén Vilaróโ€™s prize that Gate2Brain obtained for the โ€ฆSee details»

Gate2Brain - Funding, Financials, Valuation & Investors - Crunchbase

Gate2Brain is a biotech company to improve drug delivery with peptide-based patented technology. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. ...See details»

Launch of Gate2Brain, the โ€œkeyโ€ to transporting drugs into the โ€ฆ

Jul 9, 2020 Researchers from IRB Barcelona, the University of Barcelona (UB) and the Sant Joan de Déu Research Institute - Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a โ€ฆSee details»

Gate2Brain - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Gate2Brain is a biotech company to improve drug delivery with peptide-based patented technology. New. Resources. Advanced Search. ... Experience the new Crunchbase, powered โ€ฆSee details»

Gate2Brain - Tech Barcelona

Gate2Brain pursues its goals using a radically innovative peptide-based patented technology platform. G2B-001, Gate2Brain flagship product and proof of concept of the technology, offers โ€ฆSee details»

Investors - Gate2Brain

Mar 19, 2025 OUR VALUE PROPOSITION. Gate2Brain is an early-stage biotech company that aims to improve drug delivery across biological barriers using an innovative peptide-based โ€ฆSee details»

Gate2Brain has reached a major milestone as its innovative drug, โ€ฆ

Oct 31, 2024 Gate2Brain, a spin-off from the IRB Barcelona, The University of Barcelona and Sant Joan de Deu Barcelona Hospital, has reached a major milestone as its innovative drug, โ€ฆSee details»

Gate2Brain - Contacts, Employees, Board Members, Advisors

Gate2Brain is a biotech company to improve drug delivery with peptide-based patented technology. New. Resources. Advanced Search. Start Free Trial ... Log In. Experience the โ€ฆSee details»

Gate2Brain Technology Validated for Antibody Delivery to the

Barcelona, Spain โ€“ April 2025 New research highlights how advanced peptide shuttlesโ€”the core of Gate2Brain technology platformโ€”are poised to revolutionize drug delivery across the blood ...See details»

G2B receives funding to accelerate its transfer to the market and โ€ฆ

Jan 13, 2022 Gate2Brain, a spin-off of Sant Joan de Déu (SJD), Institute for Research in Biomedicine (IRB) Barcelona and University of Barcelona (UB) will develop a new drug using a โ€ฆSee details»

Inside the Battle Over OpenAIโ€™s Corporate Restructuring

6 days ago Aguilarโ€™s new organization, LatinoProsperity, focuses on intergenerational wealth building, and he believed cutting-edge AI chatbots such as ChatGPT would become an โ€ฆSee details»

linkstock.net © 2022. All rights reserved